Health-related quality of life, one-year costs and economic evaluation in extracorporeal membrane oxygenation in critically ill adults
Authors' conclusion
At one year after hospital admission requiring ECMO the health-related quality of life is favorable with substantial costs but considering the survival might be acceptable.
Study context
- Population
- Critically ill adults receiving extracorporeal membrane oxygenation (ECMO) in the ICU, August 2017–July 2019124 followed up at 12 months
- Participants
- 428 adults
- Outcome
- Survival, HRQOL (EQ-5D-5L) and associated healthcare costs in the first year
- Follow-up
- 1 year
Methodological detailsLimited by loss of follow-up; possibly only best-recovered patients returned questionnaires
- Limited by loss of follow-up; possibly only best-recovered patients returned questionnaires
Main finding
As reported in the abstract
- One-year mortality
- 50%
- Overall health status (VAS, scale 0-100) at 12 months
- 73.6
- Mean total costs during first year (± as printed), hospital costs the major contributor
- $204,513 ± 211,590
- Follow-up costs
- $53,752 ± 65,051
- Costs of absenteeism
- $7317 ± 17,036
Observational data: associations, not effects.
Original publication
Health-related quality of life, one-year costs and economic evaluation in extracorporeal membrane oxygenation in critically ill adults. J Crit Care. Published 17 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →